fenofibrate has been researched along with glucose, (beta-d)-isomer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butler, V; Gilleard, JS; Ivens, A; Laing, R; Laing, ST; Ravikumar, S; Woods, DJ | 1 |
| Han, N; Liu, Z; Xiao, B; Yin, J; Zhou, C; Zhou, J | 1 |
| Jaffa, FM; Johnson, E; Kalyani, RR; Shubrook, JH; Skolnik, N | 1 |
| Barakat, W; ELFayoumi, HM; Elshazly, S; Sabaa, M; Youns, M | 1 |
4 other study(ies) available for fenofibrate and glucose, (beta-d)-isomer
| Article | Year |
|---|---|
Characterization of the xenobiotic response of Caenorhabditis elegans to the anthelmintic drug albendazole and the identification of novel drug glucoside metabolites.
Topics: Albendazole; Animals; Anthelmintics; Caenorhabditis elegans; Chromatography, High Pressure Liquid; Drug Resistance; Enzyme Induction; Fenofibrate; Gene Expression Profiling; Glucosides; Intestines; Metabolic Detoxication, Phase I; Metabolic Detoxication, Phase II; Mutation; Oligonucleotide Array Sequence Analysis; PPAR alpha; Tandem Mass Spectrometry; Tubulin | 2010 |
Beneficial effects of neomangiferin on high fat diet-induced nonalcoholic fatty liver disease in rats.
Topics: Amino Acid Transport System ASC; Animals; Body Weight; Carnitine O-Palmitoyltransferase; Cholesterol; Coenzyme A Ligases; Diet, High-Fat; Fenofibrate; Gene Expression Regulation; Glucosides; Humans; Lipid Peroxidation; Lipoproteins, LDL; Liver; Male; Non-alcoholic Fatty Liver Disease; PPAR alpha; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Xanthones | 2015 |
Reducing CV risk in diabetes: An ADA update.
Topics: Antihypertensive Agents; Aspirin; Benzhydryl Compounds; Cardiovascular Diseases; Contraindications; Creatinine; Diabetes Complications; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Drug Chronotherapy; Ezetimibe; Fenofibrate; Glucosides; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypertension; Hypoglycemic Agents; Hypolipidemic Agents; Life Style; Liraglutide; Metformin; Niacin; PCSK9 Inhibitors; Platelet Aggregation Inhibitors; Risk Reduction Behavior; Thiazolidinediones | 2017 |
Anticancer activity of salicin and fenofibrate.
Topics: Animals; Antineoplastic Agents, Phytogenic; Benzyl Alcohols; Carcinoma, Ehrlich Tumor; Cell Survival; Female; Fenofibrate; Glucosides; Humans; MCF-7 Cells; Mice; Tumor Burden | 2017 |